瀟äŒãšããŒãããŒã·ãã
䜿åœã®å®çŸãšå°å瀟äŒã®æŽ»æ§åã®ããã«ããŒãããŒã·ãããçµã ã
Elsevierã¯çæ§ã®ç®æšå®çŸããµããŒãããŸã
å£äœãæè²æ©é¢ã倧åŠåºçãšã®åºçããŒãããŒã·ããã¯å šãŠãŠããŒã¯ã§ãããElsevierã¯çæ§ã®äœ¿åœãšã³ãã¥ããã£ãŒããµããŒãããæŠç¥ãä¿¡ããŠããŸããæŠç¥çã€ã³ãµã€ããåè¶ãã財åãã³ã³ãã³ããžã®åºç¯ãªé¢äžããªãŒãã³ã¢ã¯ã»ã¹ãäž»èŠãªåžå Žã§ã®æé·ããããŠçæ§ãšãã®ã³ãã¥ããã£ã®ããã«æ匷ã®æ¯æŽãå¯èœã§ãããšããèªèãéãããäžè²«æ§ã®ããåªããåºçæ瞟ææãæäŸããããšã«èªããæã£ãŠããŸãã
åçš®åŠäŒææ°èšäº
Elsevier Societies and Partnerships
ç®æšã®å®çŸã«åããŠ
æŠç¥çããžã§ã³
Elsevier ã®æ¥çããªãŒãããããŒã«ãšè±å¯ãªçµéšã¯ãå ·äœçãªç®æšãäžå¿ãšããä»åŸã®æŠç¥ã«æ å ±ãæäŸãã圢æããã®ã«åœ¹ç«ã¡ãŸãã çŸä»£ã¯äžç¢ºå®ãªæ代ã§ãããScopus ããŒã¿ã«è£ä»ããããããŒã¿äž»å°ã®ã¢ãããŒãã«ãã£ãŠãçŸåšããã³å°æ¥ã®ãžã£ãŒãã«ããã°ã©ã ã«ã€ããŠé©åãªéžæãã§ãããããæäŒãã§ããæŽå¯åãšäººèãåããŠããŸãã Elsevier ã¯äžçã®ç 究ææã® 18% ãåºçãã被åŒçšæ°ã® 27% ã®ã·ã§ã¢ãç²åŸããŠãããããã¯æ¥çå¹³åãå€§å¹ ã«äžåãç 究å質ãæäŸãããšããåŒç€Ÿã®åãçµã¿ãšåŒ·ã¿ã瀺ããŠããŸãã
åŠäŒããã³æå±ã¡ã³ããŒã«å¯Ÿããæ匷ã®ãµããŒã
å人çãªé¢äžãšåæãããèšç»ã®å®è¡ã確å®ã«ããä¿èšŒããããã«ãElsevierã®ååºç瀟ããäž»ãªé£çµ¡çªå£ãšãªããåºç管çãããŒã±ãã£ã³ã°ãåæãªã©ãžã®ã¢ã¯ã»ã¹ãæäŸããŸãã ããã«ãåŠäŒã«ããåºçãç 究ãšç§åŠã®é²æ©ãžã®åãçµã¿ã®äžå¿ã«æ®ããåœç€Ÿã®ãªãŒããŒã·ããããŒã ã®ãµããŒããšå šé¢çãªã³ãããã¡ã³ããå®å¿ããå±ãããŸããåœç€Ÿã®åºçããã³ãµããŒãããŒã ã¯ãCell ãLancet ãšåçã®å°éç¥èãæäŸããçæ§ã®åºçãšçµæžçæåã®ããã«å šåãå°œãããŸãã
åè¶ããèè ãç·šéè ãèªè ã®ææ
Elsevierã®åºçãµããŒããšãµãŒãã¹ã¯ãèè ãç·šéè ãèªè ãããåžå Žã®ãã³ãããŒã¯ã«å¯ŸããŠé«ãè©äŸ¡ãåŸãŠããŸããããã¯ãæ¥çããªãŒããããšã«ãŒãã¢ã®æçš¿ã·ã¹ãã ãæéãç¯çŽããªããç¬èªã®æŽå¯ãæäŸããèè ã»ç·šéè åãããŒã«ãå質ãšã¹ããŒãã«éç¹ã眮ããäžæµã®å¶äœãæ¥çããªãŒãããåºçãã©ãããã©ãŒã ã«ãã£ãŠããããããŠããŸãã
Elsevier ç¬èªã®ããŒã¿äž»å°åã¢ãããŒãã«ãããæé«ã®ã³ã³ãã³ããç¹å®ãå§èªãç²åŸããããšãã§ããŸãããŸããScienceDirect ãšåœç€Ÿã®ãžã£ãŒãã«ãã©ã³ããµã€ãã¯ããã®ã³ã³ãã³ããä»ã®è¿œéãèš±ããªãç¥å床ã§æäŸãã泚ç®ãéããäžçäžã«æµžéãããããšãã§ããŸãã
ãªãŒãã³ã¢ã¯ã»ã¹ãžã®æ³šåãšå®çžŸ
äžçææ°ã®ãªãŒãã³ã¢ã¯ã»ã¹åºç瀟ã§ããElsevierã¯ã750èªä»¥äžã®ãã«ãªãŒãã³ã¢ã¯ã»ã¹ãžã£ãŒãã«ãçºè¡ããŠãããå€ãã®åŠäŒã®ãªãŒãã³ã¢ã¯ã»ã¹å°å ¥ã«è²¢ç®ããŠããŸããã
Elsevierã¯ãèè ã®ããŒãºãæºããããšã«å šåãå°œãããŠãããåŠè¡èªã®åµåããªãŒãã³ã¢ã¯ã»ã¹ãžã®è»¢æã賌èªãšãªãŒãã³ã¢ã¯ã»ã¹ã®ããŒããã©ãªãªãæåãããããã®éçºãPlan SãOSTPã®ãããªã€ãã·ã¢ãã£ããžã®å¯Ÿå¿ãTransformative AgreementsãéããåŠäŒã®æé·ãæ¯æŽããããšã«ãããŠãè±å¯ãªçµéšãæããŠããŸãã
ASBMBïŒæ°ããã¿ã/ãŠã£ã³ããŠã§éãïŒãšPSAã¯ãæè¿Elsevierããã³ãã«ãŽãŒã«ãã»ãªãŒãã³ã¢ã¯ã»ã¹ã«åãæ¿ãã2ã€ã®åŠäŒã§ãã
Leadership in growth markets
ã°ããŒãã«ãªè²©å£²ããŒã ãšç¬èªã®ã€ã³ãã©ãšãªãœãŒã¹ã«ãããçããŸã®åçãæ倧åããããå€ãã®ãã€ã€ã«ãã£ãéå ããããšãã§ããŸããåœç€Ÿã¯ã財åãªã¹ã¯ã管çããããšããã客æ§ã®ãåžæãšå¿ èŠæ§ã«é æ ®ããŠããŸããçæ§ãšãšãã«é·æçãªèŠéã«ç«ã¡ãæç¶å¯èœãªæ¹æ³ã§æ°ããªããžãã¹ã¢ãã«ã«ç§»è¡ã§ãããããè³éæäŸã®åŒãåããæ¡ä»¶ã®æ§ç¯ãªã©ãè¡ããŸãã
ä¿¡é Œæ§ã®é«ã匷åºãªè²¡å
Elsevierã¯ãçæ§ã«ãšã£ãŠå å®ãªè²¡åãªã¿ãŒã³ãéèŠã§ããããšãç解ããŠãããåœç€Ÿã®è²¡åå¥çŽã¯ãçæ§ã®ãªã¿ãŒã³ãæ倧åãããªã¹ã¯ãæå°åãããžã£ãŒãã«ã®é·æçãªç¹æ ã確ä¿ããããšãåºæ¬ãšããŠããŸãã
ã°ããŒãã«ãªè²©å£²ããŒã ãšç¬èªã®ã€ã³ãã©ãšãªãœãŒã¹ã«ãããçããŸã®åçãæ倧åããããå€ãã®ãã€ã€ã«ãã£ãéå ããããšãã§ããŸããåœç€Ÿã¯ã財åãªã¹ã¯ã管çããããšããã客æ§ã®ãåžæãšå¿ èŠæ§ã«é æ ®ããŠããŸããçæ§ãšãšãã«é·æçãªèŠéã«ç«ã¡ãæç¶å¯èœãªæ¹æ³ã§æ°ããªããžãã¹ã¢ãã«ã«ç§»è¡ã§ãããããè³éæäŸã®åŒãåããæ¡ä»¶ã®æ§ç¯ãªã©ãè¡ããŸãã
åŠäŒããŒãããŒã·ãã
ãåãåãã
åºçç®æšã®éæãåŒç€Ÿãã©ã®ãããªãæäŒããã§ããããã話ãããŠããã ãæ©äŒããåŸ ã¡ããŠããŸãã詳现ã«ã€ããŠããŸã Elsevier ãšããŒãããŒãçµãã¡ãªããã«ã€ããŠã¯ãElsevier(æ°ããã¿ãïŒãŠã£ã³ããŠã§éã)ãŸã§ãåãåãããã ããã
ããŒã ã®ã玹ä»
å£äœã®ææ°æ å ±
Elsevier ã®å£äœã®ææ°æ å ±ã¯ãä»æ¥ã®åºçæ¥çã圢æããäž»èŠãªèª²é¡ã«é¢ããè«æãç¹éããã€ã³ãµã€ãã«å¯ãã ãã¥ãŒã¹ã¬ã¿ãŒ/ããã°ã§ããããã«ã¯ãå£äœããŒãããŒã«ãã£ãŠæžãããããŸãã¯å£äœããŒãããŒã«ã€ããŠæžããããã±ãŒã¹ã¹ã¿ãã£ããå«ãŸããŠãããç§ãã¡å šå¡ãéåçãªçµéšããåŠã³ãçºå±ããè¯ãæ©äŒãšãªããŸãã